Brook Byers

From Wikipedia, the free encyclopedia

This article needs sources or references that appear in reliable, third-party publications.
Primary sources and sources affiliated with the subject of the article are generally not sufficient for a Wikipedia article. Please include more appropriate citations from reliable sources, or discuss the issue on the talk page.
This article has been tagged since November 2007.

Brook Byers is a senior partner at Kleiner Perkins Caufield & Byers and the brother of Stanford University Professor Tom Byers.

He is currently on the Board of Directors of nine companies, most recently joining OptiMedica,CardioDX, Genomic Health Incorporated, Five Prime Therapeutics, Pacific Biosciences, Inc. and XDx, Inc.^[1] Previously, he served on the Board of Directors of Idec Pharmaceuticals (Chairman), Athena Neurosciences (Chairman), Signal Pharmaceuticals, Arris Pharmaceuticals, Pharmacopeia, Ligand Pharmaceuticals (Chairman), Hybritech (Chairman), Genprobe, Nanogen, and others.

Brook was President and a Director of the Western Association of Venture Capitalists and is a contributing author of the book Guide to Venture Capital. He is currently a board member of the University of California at San Francisco Medical Foundation, the California Healthcare Institute, the NewSchools Venture Fund, Stanford’s Bio-X Advisory Council, the Stanford Eye Council and TechNet. He is Co-Chair of the UCSF Capital Campaign.

He was formerly a Director of the Entrepreneurs Foundation, the Asian Art Museum of San Francisco, the Stanford University Graduate School of Business Advisory Council, UCSF's That Man May See Vision Research Foundation (Chairman) and the Georgia Tech Advisory Board.

Raised in Atlanta, Georgia, he earned a bachelor's degree in electrical engineering in 1968 from Georgia Tech and an MBA from Stanford University.